baber/WOPTO huggingface dataset:
Patent CS-273491-B1 (CS)
Title: Method of granulate preparation of raw materials on base of magnesium oxide
Inventor: BUMBALEK VACLAV ING
IPC: B01J2/28
Filed: 1988-11-08
Abstract: The method concerns a method of production of granulate from materials based on magnesium oxide mainly from caustically calcinated magnesite or from a product of its physical or heat treatment. The principle of the solution consists in the fact that a raw matter based on magnesium oxide, from which a granular fraction has been separated, which by the grain size exceeds a defined granulometric composition, by means of overgrinding and/or addition of dust from the calcination process, which has a loss by annealing at most 25 percent, is treated in such a way that it contains at least 10 percent by weight of 0.2 granular fraction. Then the input homogenization is homogenized with 1 to 15 percent by weight, related to the weight of the raw matter based on magnesium oxide, at least one binding agent, and after pre-humidification to humidity of at least 5 percent it is pelletised and the obtained pellets are after pre-drying to a humidity of 20 percent by weight sorted for obtaining the granulate with the requires defined granulometric composition, while the oversized and/or the oversized product is returned back to the homogenisation process.<IMAGE>
Patent CS-219114-B1 (CS)
Inventor: BLAZICEK IVAN
IPC: D06F23/02
Filed: 1981-10-14
Abstract: Vynález spadá do výroby pracích a odstřeďovacích
strojů a týká se zařízeni k praní
a Odstřeďování drobných pevných předmětů,
například syntetických válcových nádobek
na ptráškovou c-xidovanou celulózu,
které zahrnuje prací káď a děrovaný horizontální
pracovní buben. Tento pťaeovní, buben
je pevně uchycený na volném konci
hnacího hřídele převodového soukolí hnacího
elektromotoru a s nimi je připevněný
na -ovládací páce, která je přemístitelná kolem
svóh’0* 1 místa otáčení tak, že pracovní buben
může zaujmout plnicí nebo prací ne-bd
odstřeďovací polohu.
Patent CS-232903-B1 (CS)
Inventor: KADLEC VLASTIMIL
IPC: C10G45/08
Filed: 1982-10-22
Abstract: Vynález se týká petrochemického zpracování
ropy a popisuje způsob spoleěného
zpracovaní destilátů z tepelné přeměny
uhlí s benziny z pyrolýzy uhlovodíků.
Destiláty z tepelné přeměny uhlí vroucí do
180 °C se katalyticky hydrogenačně rafinují,
načež se získaný hydrogenát zbaví
destilací rozpuštěných plynů, případně
uhlovodíků C5 a takto upravený se spoleěně
s benzentoluen-xylenovou frakcí oddělenou
z hydrogenovaného pyrolyzního benzinu
v poměru 1:20 až 20:1 podrobí dealkylaci
na chromovém katalyzátoru a z reakěního
produktu se oddělí benzen.
Patent CS-252130-B1 (CS)
Inventor: SRUTA FRANTISEK
IPC: D01F11/04
Filed: 1985-11-28
Abstract: Způsob úpravy polyesterového vlákna
s obsahem do 5 % hm. uhličitanu vápenatého
působením vodného roztoku kyseliny
o koncentraci 0,1 aš 20 % hm. na povrch
vlékna před nebo v průběhu dloužení,
případně v průběhu dalšího zpracování
vláken, s výhodou před nebo v průběhu
barvení. K působení ne povrch vlákna
lze použít předevěím zředěný roztok kyseliny
solné nebo octová. Po působení
kyseliny se vystaví vlákno účinku zásaditého
roztoku hydroxidu sodného nebo
draselného. Úpravou povrchu vlákna se
dosáhne zlepSení jeho sorpčních vlastností.
Patent CS-237822-B1 (CS)
Inventor: FULIER JOZEF
IPC: B21J15/18
Filed: 1982-12-02
Abstract: Učelom vynálezu je automatické spustenie
nitovacej jednotky.
Uvedeného účelu sa dosahuje vynálezem,
ktorého podstatou je, Že pozostáva z pracovného
valca s odpruženým piestom, 'ktorého
piestníea je opatřená vyhadzovacom
a pevným vodidlom, v ktorom je odpružené
posuvné uložený uchopovat:. Pracovný válec
je ovládaný tlakovým médiem z rozvádzacej
komory. V tlakovej komoře je uložený
posúvač.
Patent CS-229572-B1 (CS)
Inventor: KUFA FRANTISEK ING
IPC: C22C38/04
Filed: 1982-12-21
Abstract: Ocel na odlitky se zaručenou svařitelností
a vrubovou houževnatostí, zejména pro
výrobu odlitků na armatury plynovodů a ropovodů,
pracující v extrémních podmínkách
při (—60 až + 50 °C) obsahující v hmotnostním
množství uhlík od 0,05 do 0,16%, mangan
od 0,60 do 1,60 %, křemík od 0,20 do
0,70 %, nikl od 0,3 do 1,6 °/o, vanad od 0,05
do 1,6 %, fosfor od 0,003 do 0,020 %, síru
od 0,003 do 0,020 %, měď od 0,02 do 0,15 %,
chrom od 0,03 do 0,15 °/o, hliník od 0,02 do
0,10 % a molybden stopy až 0,10 %. Dále může
obsahovat cér od 0,04 do 0,25 %.
Způsob tepelného zpracování odlitků z
této oceli spočívá v homogenizačním žíhání
na teplotě 950 až 1100 °C, ochlazení volně
na vzduchu pod teplotu 450 °C, následném
normalizačním žíhání na teplotě 880 až 950
stupňů Celsia s ochlazením ve vodě pod teplotu
400 °C a v dalším popouštění v rozmezí
teplot 550 až 680 °C s následujícím ochlazením
ve vodě.
Patent CS-219249-B1 (CS)
Inventor: ROZANSKY ZBYNEK
IPC: C14B17/06
Filed: 1981-12-21
Abstract: Vynález se týká oboru koželužských strojů
a zařízení pro koželužny.
Řeší jednodušší -ovládání koželužského
stroje pomocí nožní šlapky, snížení počtu
sešlápnutí na četnost odpovídající zdravotnickým
předpisům.
Podstata vynálezu spočívá v tom, že po
průchodu koželužské usně strojem, se stroj
automaticky otevře, aniž by bylo nutné sešlápnout
nožní šlapku.
Patent DK-172632-B1 (DK)
Inventor: GEIGER ROLF
IPC: C07K14/62
Filed: 1984-09-21
Granted: 1999-03-22
Abstract: 1. Claims for the Contracting States : BE CH DE FR GB IT LI LU NL SE A medicament having a delayed action for the treatment of diabetes mellitus, comprising at least one insulin derivative of the formula I see diagramm : EP0137361,P16,F1  in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH2 and des-B30 human insulin Phe**B30 -NH2 and a pharmaceutically acceptable carrier. 1. Claims for the Contracting State : AT A process for the preparation of a medicament having a delayed action for the treatment of diabetes mellitus, which comprises bringing into a suitable dosage form at least one insulin derivative of the formula I  see diagramm : EP0137361,P17,F1  in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH, and des-B30 human insulin Phe**B30 -NH2 Phe**B30 -NH2 and a pharmaceutically acceptable carrier.
Patent FI-101334-B1 (FI)
Inventor: LANDEGHEM MARC VAN
IPC: H04M3/42
Filed: 1988-08-24
Granted: 1998-05-29
Abstract: When the line is busy, higher-priority features are initiated in each case automatically after defined periods of time with no action being taken by the calling party. 
<IMAGE>
Patent FI-104115-B1 (FI)
Inventor: HERRMANN ROBERT
IPC: F02D19/08
Filed: 1992-04-10
Granted: 1999-11-15
Abstract: The invention relates to a fuel injection method for a diesel type internal combustion engine, using a main gaseous fuel and a secondary liquid fuel in the form of a pilot injection intended to initialise the combustion of the main fuel, the liquid fuel being injected by an injection pump designed so as to enable the engine to reach its maximum power only by use of the liquid fuel, characterised in that the pilot injection consists of a mixture of water and of liquid fuel.
Patent IE-58322-B1 (IE)
Title: Bornane derivatives
IPC: E04B1/343
Filed: 1985-04-23
Abstract: This invention relates to new pyranoderivatives of the formula:  wherein X1 is H, Cl or Br and Z stands for:  wherein X2 is H, Cl or Br, T is O or S and Y stands for an arabinose, xylose or ribose moiety, the acetylated form of the same, with either a pyranose or furanose configuration and bound to the R moiety of either the alpha or the beta anomer, to a preparation process of said compounds from stoichiometric proportions of the compound R-H and of the selected ose, and to therapeutic compositions, the active ingredient of which comprises at least one of these compounds associated with an appropriate diluent or carrier.
Patent IE-51093-B1 (IE)
Title: Microcomputer apparatus with video display capability
IPC: G06F3/0485
Filed: 1981-05-18
Abstract: A microcomputer system with video display capability, particularly suited for small business applications and home use is described. The CPU performance is enhanced by permitting zero page data to be stored throughout the memory. The circuitry permitting this capability also provides a pointer for improved direct memory access. Through unique circuitry resembling "bank switching" improved memory mapping is obtained. Four-bit digital signals are converted to an AC chroma signal and a separate luminance signal for display modes. Display modes include high resolution modes, one of which displays 80 characters per line.
Patent IE-61992-B1 (IE)
Title: Receptor of the small rhinovirus receptor group
Inventor: BLAAS DIETER DR
IPC: C07K16/00
Filed: 1988-04-13
Abstract: A receptor from the small receptor group of human rhinoviruses, its purification and use.
Patent IE-52043-B1 (IE)
Title: Imidazobenzothiadiazepines process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application
IPC: C07D233/84
Filed: 1981-06-11
Abstract: The invention concerns the compounds of the Formula I   <IMAGE> wherein each of R1 and R2 is hydrogen, alkyl, alkanoyl, halogeno, cyano, carboxy, carbalkoxy, carbamoyl, sulfamoyl, mono- or di-alkyl-(carbamoyl or sulfamoyl); Ph is 1,2-phenylene, unsubstituted or substituted by up to two identical or different members selected from alkyl, alkoxy, alkylthio, halogeno, trifluoromethyl, sulfamoyl, mono- or di-alkylsulfamoyl; each of CmH2m and CnH2n is alkylene separating both nitrogen atoms by 2 or 3 carbon atoms, and R3 is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, phenyl-alkoxycarbonyl or hydroxyalkyl, wherein the hydroxy group is separated from the nitrogen atom by at least 2 carbon atoms; their N- and/or S-oxides, and alkyl quaternary derivatives thereof salts of all these compounds. The compounds exhibit neuroleptic activity. They are prepared by condensing a compound of the general Formula III or a salt thereof with a compound of the general Formula IV   <IMAGE> wherein X is halogeno, alkoxy, alkylthio, cyanato or thiocyanato; Y is hydrogen or an alkali metal; p is an integer from 0 to 2, and the remaining symbols have the meaning given for formula I.
Patent IE-38192-B1 (IE)
Title: A process and apparatus for putting yarns on a bobbin winding apparatus
IPC: B65H75/28
Filed: 1973-09-03
Abstract: Two yarns or the like, preferably freshly spun yarns, are put onto a bobbin-winding device capable of rotating at high peripheral speeds. A movable guide means is positioned approximately midway between two yarn winding zones of the winding device to hold the two yarns together as they are put on the winding device. The guide is moved clear of the yarns releasing same after the yarns are connected to the winding device. The yarns are preferably wound on two cores or tubes detachably fitted on the winding device so as to form a butt joint between adjacent tube ends in the region in which the yarns are initially wound on the winding device, this region being defined by the movable guide means.
[US3880371A]
Patent IE-54831-B1 (IE)
Title: Implanting device and implant magazine
IPC: A61D/
Filed: 1982-09-28
Abstract: A cylindrical implant magazine (100) having open-ended implant-containing chambers (103) with slots (104) communicating with the surface of the magazine so that the open-sided chambers can expand slightly during ejection of the implants.
Patent IE-61337-B1 (IE)
Title: Treatment of immuno-resistant disease
Inventor: CUMMINS JOSEPH M
IPC: A61K38/21
Filed: 1987-11-06
Abstract: Autoimmune disorders are treated by the administration of human interferon, particularly IFN- alpha or IFN- beta , at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The interferon is administered in a solid dosage form, e.g., a saliva-dissolvable lozenge.
Patent IE-60964-B1 (IE)
Title: Zootechnical compositions containing a beta-adrenergic
IPC: A23K1/16
Filed: 1987-12-10
Abstract: The zootechnical compositions or combinations contain:
 a) a zootechnical composition containing a beta-adrenergic agent,
 b) a zootechnical composition containing a steroid of formula (A): 
<IMAGE>
 in which X represents hydrogen, an acyl radical derived from a (C1-C18) carboxylic acid or a (C1-C6) alkyl radical in which one carbon may be replaced by an oxygen, and optionally a second steroid for use simultaneously, separately or spread over a period of time. 
<??>The compositions and combinations of the invention enable the weight gain and the quality of the meat to be improved in livestock.
Patent LU-100679-B1 (LU)
Title: Silenced head for fire extinguishing gas discharge
Inventor: ANDREAS THOMAS
IPC: B05B1/00
Filed: 2018-01-21
Granted: 2019-07-22
Abstract: The invention is directed to a silenced head (2) for a gas discharge, in particular for a fire extinguishing gas discharge, comprising a base (4) with an opening (4.3, 14) forming a gas input; a closed wall (6) made of porous material and extending longitudinally from the base so as to form a distal opening; a front wall (8) made of porous material closing the distal opening of the closed wall (6); a fastening ring (10) arranged against an outer face of the front wall (8) and attached to the base (4) by longitudinal screws (12); wherein the ring (10) comprises a ring portion (10.1) and webs (10.3) extending radially from the ring portion (10.1) so as to form contact surfaces for the front wall (8).
Patent LU-101353-B1 (LU)
Title: Affinity sensor, in particular qcm sensor
Inventor: KRISHNAMOORTHY SIVASHANKAR
IPC: G01N29/02
Filed: 2019-08-19
Granted: 2021-02-24
Abstract: An aspect of the invention pertains to an affinity sensor for sensing an analyte in a fluid, comprising an interface for contacting the fluid and adsorption of the analyte. The interface comprises a binary pattern of nanoscale regions having affinity for the analyte and a passivated region. The nanoscale regions are isolated from one another by the passivated region in such a way that adsorption of the analyte on the interface is confined to the nanoscale regions. The nanoscale regions have diameters comprised in the range from 5 to 200 nm. The nanoscale regions have together a surface area amounting to at least 10% of the surface area of the interface. A further aspect of the invention relates to a method of using such a sensor.
Patent LU-102248-B1 (LU)
Title: Impregnation unit for fiber roving
Inventor: ELSBURY BRAD
IPC: B29B15/12
Filed: 2020-11-30
Granted: 2022-05-31
Abstract: An impregnation unit (10) for impregnating a fiber roving, comprising: a housing (12) having an internal pathway (18) extending, along a feed direction (A1), between an inlet aperture (14) and an outlet aperture (16), wherein in use a fiber roving (15) is drawn through the pathway; fiber spreading means (20), wetting means (30) and pressing means (40) arranged along the pathway to act upon the fiber roving passing through the pathway (18); wherein the wetting means (30) include at least one soft porous body (32), which in use is soaked with liquid matrix material, the at least one soft porous body being arranged to be in contact with the moving fiber roving to apply liquid matrix material thereon; and wherein the pressing means (40) are configured to force the applied matrix material into the fiber roving.
Patent LU-502114-B1 (LU)
Title: Method for rapidly preparing quartz needles with variable taper in batch
Inventor: ZHANG BO
IPC: H01J49/00
Filed: 2022-05-18
Granted: 2022-11-21
Abstract: The invention relates to a method for quickly preparing quartz needles with variable taper in batch. One end of a traction line is fixed on the injection pump, the other end of the traction line is fixed on the quartz capillary fixing device, the quartz capillary is fixed on the quartz capillary fixing device, and the quartz capillary is put into a centrifuge tube filled with hydrogen fluoride solution, which is arranged on a test rack to remove the polymer coating on one end of quartz capillary and fix and seal the other end of quartz capillary; one end of the quartz capillary with the polymer coating removed is put into the hydrogen fluoride solution for etching, then the quartz capillary is vertically pulled up to gradually reduce the etching range; after etching, rinse with weak alkaline aqueous solution and water in turn to obtain the variable taper quartz needle.
Patent LU-503107-B1 (LU)
Title: Method for Reconstructing Ocean bottom Seismic Data
Inventor: XU YA
IPC: G06F17/00
Filed: 2022-11-24
Granted: 2023-05-24
Abstract: The invention provides the method for reconstructing ocean bottom random sampling seismic data. And based on the sparsity of ocean bottom seismic data, the invention extracts sparse features of ocean bottom seismic by irregular curvelet transform, obtains sparse curvelet coefficient satisfying constraint conditions through multiple iterations, and then carries out regular inverse transform on the sparse curvelet coefficient to obtain reconstructed ocean bottom seismic data. The method can effectively reconstruct ocean bottom seismic data and remove noise interference.
Patent LU-503176-B1 (LU)
Title: Application of shionone in preparation of drugs for prevention and treatment of colitis
Inventor: QIAO CHEN
IPC: A61P1/04
Filed: 2022-12-12
Granted: 2023-06-12
Abstract: The present invention discloses an application of shionone in preparation of drugs for the prevention and treatment of colitis, and in particular relates to an application of shionone in preparation of drugs for the prevention and/or treatment of colitis. The present invention provides a new use of shionone, i.e., a therapeutic effect on colitis. The present invention finds that shionone may significantly inhibit local colonic inflammation in mice with colitis, reduce elevation of NLRP3 inflammasomes in the local colon of the mice, and effectively inhibit the expression of caspase-1, IL-1β and other inflammatory factors. The above results suggest that shionone may significantly improve local colonic inflammatory lesions in mice with colitis, and may be used as a drug for treating colitis.
Patent NO-305584-B1 (NO)
Inventor: KOHNERT ULRICH
IPC: B65G53/42
Filed: 1991-08-09
Abstract: The invention relates to a pharmaceutical preparation of a non-glycosylized t-PA derivative, K1K2P pro, with an enzymatic activity of at least 0.4 MU/ml and a pH of 4.5 to 6, containing citrate and at least one compound from the following group: a) ascorbic acid, b) EDTA, c) amino compounds of formula R?1R?2N -R - X, where X = SO3?H, CH(NH2?)-CO2?H, CO2?H, H, NH2? or OH, R = C1?-C9? alkylene, C3?-C6? cycloalkylene or benzylidene and R?1 and R?2, independently of each other, are H or C1?-C3? alkyl, d) guianidinobutyric acid, e) dimethylbiguanide, f) arginine, g) glucosamine, fructose, h) pyrimidine nucleosides and pyrimidine nucleotides, i) carboxylic acids substituted with one or more hydroxyl, keto and/or further carboxyl groups. The invention also relates to a drug containing the t-PA derivative K1K2P pro as the active ingredient and a process for producing it.
Patent NO-300977-B1 (NO)
Inventor: PEET NORTON PAUL
IPC: A61P25/28
Filed: 1992-03-11
Abstract: The present invention relates to certain novel 8-substituted purines as selective A1-adenosine receptor antagonists which are useful in the treatment of patients suffering from Alzheimer's disease, congestive heart failure or pulmonary bronchoconstriction.
Patent NO-304994-B1 (NO)
Inventor: ORTNER HERBERT
IPC: D21B1/32
Filed: 1993-05-19
Abstract: The invention concerns a method of processing printed waste-paper, in particular waste-paper containing at least 80 % newspaper or magazine paper, by dissolving the paper, various cleaning stages, flotation or washing and subsequently pulping to a degree of consistency of at least 20 % and, optionally, bleaching. The invention is characterized in that a second, terminal, pulping stage is carried out, optionally followed by bleaching stage. In the second pulping stage, the waste-paper is subjected to a vigorous kneading action by individually mounted rod-shaped or stud-shaped kneading elements on both the stator and rotor of the pulping machine. The stator and rotor are disposed in a pulping chamber delimited by the surfaces of two concentric cylinders. Pulping is carried out oven-dry at temperatures between 20 and 110 C, preferably 38 to 65 C, at a specific power consumption of between 30 and 100, preferably 80 kWh per ton of oven-dried paper.
Patent NO-315304-B1 (NO)
Inventor: NIELSEN PER MUNK
IPC: C12P21/06
Filed: 1993-11-29
Abstract: PCT No. PCT/DK92/00170 Sec. 371 Date Nov. 30, 1993 Sec. 102(e) Date Nov. 30, 1993 PCT Filed May 27, 1992 PCT Pub. No. WO92/21248 PCT Pub. Date Dec. 10, 1992A well tasting and organoleptically acceptable whey protein hydrolyzate is produced in high yield by a method using a combination of non-pH-stat hydrolysis and ultrafiltration. Preferably, the method is carried out by mixing a material containing at least 65% whey protein as dry matter and water to form a slurry containing a whey protein content of about 7-20%, heating the slurry to above 600 DEG  C., adjusting the pH of the slurry to about 8, hydrolyzing the slurry with at least two different proteases to a degree of hydrolysis of between 17 and 35% without adjusting the pH during hydrolysis to produce a hydrolyzed slurry, inactivating the proteases and separating the hydrolyzed slurry with an ultrafiltration unit having a cut-off value above 10,000 to form a permeate containing the whey protein hydrolyzate. One protease may be obtained from B. Licheniformis and the other from B. Subtilis. The hydrolyzed slurry or the permeate may be treated with activated carbon, and the permeate may be concentrated by nanofiltration and/or by evaporation.
Patent NO-309113-B1 (NO)
Title: Ventil
Inventor: FARRELL GREGORY A
IPC: F15C3/04
Filed: 1995-10-06
Abstract: En ventil (1) omfatter et første stivt lag (10) med en første hovedsakelig plan overflate (12), og et andre stivt lag (20) med en hovedsakelig plan andre overflate (21) og et fleksibelt lag (30) plassert mellom den første (12) og den andre (21) overflaten. Et ventilkammer er avgrenset av en konkav overflate (14) i den første overflaten (12) og en overflate (31) av det fleksible laget (30), og en første fluidpassasje (15) i det første laget (10) åpner seg inn i ventilkammeret. Et fluldkammer er avgrenset av en annen overflate (32) av det fleksible laget (30) og en konkav-konveks overflate (24,25) i den andre overflaten (21) som omfatter et indre sirkulært konvekst avsnitt (24) og et konsentrisk ringformet ytre konkavt avsnitt (25). To andre f luidpassasjer (26,27) i det andre laget (20) åpner seg inn i ventilkammeret. Når et vakuum påføres ventilkammeret, bøyes det fleksible laget (30) for å bringe den andre overflaten (32) i avstand fra den konkav-konvekse overflaten (24,25) for å tillate kommunikasjon mellom de to andre fluidpassasjene (26,27) og når et trykk påføres ventilkammeret bøyes det fleksible laget (30) for å bringe den andre overflaten (32) mot den konkav-konvekse overflaten (24,25) for å forhindre kommunikasjon mellom de andre fluidpassasjene (26,27).